The inhibition of ATX or LPAR1 using siRNA or small molecules disturbs the differentiation of MSC-derived fibroblasts, and it reduces the metastasis, migration, and cell proliferation of cancer cells [146,147,148,149]. The gene discussed is LPAR1; the disease is cancer.